- United Kingdom
- /
- Biotech
- /
- LSE:GNS
Exploring 3 High Growth Tech Stocks In The United Kingdom
Reviewed by Simply Wall St
The United Kingdom's market has recently faced challenges, with the FTSE 100 index experiencing a downturn due to weak trade data from China, which has impacted companies closely tied to its economic fortunes. In this environment, identifying high growth tech stocks requires focusing on firms that demonstrate resilience and innovation, qualities that can help them navigate broader market uncertainties and capitalize on emerging opportunities.
Top 10 High Growth Tech Companies In The United Kingdom
Name | Revenue Growth | Earnings Growth | Growth Rating |
---|---|---|---|
STV Group | 13.14% | 46.78% | ★★★★★☆ |
Pinewood Technologies Group | 27.24% | 25.48% | ★★★★★☆ |
Facilities by ADF | 48.47% | 189.97% | ★★★★★☆ |
Redcentric | 5.32% | 67.90% | ★★★★★☆ |
Altitude Group | 24.51% | 30.10% | ★★★★★☆ |
YouGov | 7.55% | 56.01% | ★★★★★☆ |
Windar Photonics | 36.65% | 46.33% | ★★★★★☆ |
Beeks Financial Cloud Group | 22.12% | 36.94% | ★★★★★☆ |
Faron Pharmaceuticals Oy | 46.41% | 26.78% | ★★★★★☆ |
Cordel Group | 33.50% | 148.58% | ★★★★★☆ |
Click here to see the full list of 44 stocks from our UK High Growth Tech and AI Stocks screener.
Let's review some notable picks from our screened stocks.
M&C Saatchi (AIM:SAA)
Simply Wall St Growth Rating: ★★★★☆☆
Overview: M&C Saatchi plc is a global advertising and marketing communications company operating across the United Kingdom, Europe, the Middle East, Africa, the Asia Pacific, and the Americas with a market cap of £215.17 million.
Operations: The company generates revenue through its advertising and marketing communications services across various regions including the UK, Europe, the Middle East, Africa, Asia Pacific, and the Americas. Its financial performance is reflected in a market cap of £215.17 million.
M&C Saatchi, navigating the challenging landscape of UK's high-growth tech sector, has demonstrated resilience with a notable shift towards operational efficiency and strategic leadership changes. Despite an expected annual revenue decline of 15.4%, the company's earnings are forecast to surge by 27.4% annually, outpacing the UK market average growth of 14%. Recent appointments, like Nadja Bellan-White as CEO for North America, underscore a commitment to integrating and optimizing regional operations which could bolster future performance. This strategic pivot towards efficiency and leadership in high-growth areas suggests potential for robust future prospects despite current revenue headwinds.
- Click to explore a detailed breakdown of our findings in M&C Saatchi's health report.
Explore historical data to track M&C Saatchi's performance over time in our Past section.
Genus (LSE:GNS)
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Genus plc is an animal genetics company with operations across North America, Latin America, the United Kingdom, Europe, the Middle East, Russia, Africa, and Asia and has a market cap of £1.23 billion.
Operations: Genus focuses on animal genetics, providing advanced breeding services and products across multiple regions including North America, Latin America, the UK, Europe, the Middle East, Russia, Africa, and Asia. The company generates revenue primarily through its bovine and porcine genetics segments.
Genus plc, amidst a challenging UK tech landscape, has shown resilience with its strategic focus on innovation and market adaptation. With earnings forecasted to grow by 46.67% annually, the company is positioned to outpace the average UK market growth significantly. Despite a modest revenue increase of 3.9% per year, Genus is making notable strides in profitability, expected to turn profitable within three years—a promising outlook given the current unprofitability status. Recent leadership changes, including the anticipated departure of Professor Jason Chin from the board, signal a fresh perspective that could further drive forward-thinking strategies and enhance its scientific advisory capabilities.
Pinewood Technologies Group (LSE:PINE)
Simply Wall St Growth Rating: ★★★★★☆
Overview: Pinewood Technologies Group PLC is a cloud-based dealer management software provider serving the automotive industry in the UK and internationally, with a market cap of £293.93 million.
Operations: Pinewood Technologies Group generates revenue primarily through its software solutions targeted at the automotive industry, with a reported revenue of £22.62 million from this segment.
Pinewood Technologies Group, following a recent equity offering raising £35.67 million, is poised for expansion with its Pinewood Automotive Intelligence platform. This strategic move is evidenced by a significant new contract with Global Auto Holdings to implement this platform across multiple regions, expected to substantially boost earnings. With an annual revenue growth forecast at 27.2% and earnings growth at 25.5%, Pinewood outstrips the UK market averages significantly, despite past challenges of shareholder dilution and a stark 81.6% decline in earnings last year. This trajectory suggests robust potential in leveraging technology within the automotive sector, especially as they prepare for major rollouts starting in 2026.
Next Steps
- Navigate through the entire inventory of 44 UK High Growth Tech and AI Stocks here.
- Already own these companies? Link your portfolio to Simply Wall St and get alerts on any new warning signs to your stocks.
- Unlock the power of informed investing with Simply Wall St, your free guide to navigating stock markets worldwide.
Curious About Other Options?
- Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
- Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
- Find companies with promising cash flow potential yet trading below their fair value.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
New: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
About LSE:GNS
Genus
Operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia.
Very undervalued with reasonable growth potential.